Raven Jaeger - May 18, 2022 Form 3 Insider Report for Diffusion Pharmaceuticals Inc. (DFFN)

Signature
/s/ William R. Elder, attorney-in-fact for the Reporting Person
Stock symbol
DFFN
Transactions as of
May 18, 2022
Transactions value $
$0
Form type
3
Date filed
8/26/2022, 06:06 PM
Next filing
Aug 26, 2022

No securities are beneficially owned.